Your event should be here ! To publish, manage, promote... To learn or to be formed ... Online registrations

Site language : English - Français
Ref : 28789
Event :European NeoAg Summit 2019

Dates :Tuesday April 23rd, 2019 - Thursday April 25th, 2019

Location :Amsterdam Marriott Hotel
12 Stadhouderskade
1054 ES Amsterdam, Netherlands

Type :Conference & Seminar - International audience

Accreditation :--


 

Further information

 

The 3rd Annual European NeoAg Summit is the leading industry-dedicated meeting focused on advancing personalised cancer immunotherapy through neoantigen targeting.

Over the last year, there has been a record number of neoantigen-based therapies heading into and through the clinic. In addition, exciting collaborations that bring significant investment into the space means that tumour-specific antigen targeting is set to explode.

At the European NeoAg Summit, we bring together the leading pharma and biotech companies to discuss:

-Reducing the discordance between various neoantigen prediction methods
-Maximising the immune response to neoantigens
-Shortening the needle-to-needle time of personalised cancer immunotherapy
-Navigating the evolving regulatory landscape to faster approval

Join the leaders from BioNTech, Genentech, Genocea, Gritstone Oncology, Agenus, Ziopharm, Vaccibody, the European Medicines Agency and many more to spur on more efficacious personalised cancer vaccines and cell therapies.

URLs:
Website: https://go.evvnt.com/339791-0?pid=4319 
Tickets:   https://go.evvnt.com/339791-1?pid=4319 
Brochure: https://go.evvnt.com/339791-2?pid=4319

Prices:
Conference + 2 Workshops: EUR 3397.0,
Conference + 1 Workshop: EUR 2898.0,
Conference only: EUR 2399.0,
Workshop Only (Each): EUR 599.0

Speakers: John Castle, Associate Vice President, Head of Translational Medicine and Bioinformatics, Agenus, Andrew Ishizuka, Chief Scientific Officer, Avidea Technologies, Mathias Vormehr, Head of Cancer Vaccines, BioNTech, Michal Bassani-Sternberg, Sternberg Director, Immunopeptidomics Unit Center of Experimental Therapeutics, CHUV, Asterios Tsiftsoglou, Committee for Advanced Therapies Member, European Medicines Agency, Lélia Delamarre, Senior Scientist, Cancer Immunology Research, Genentech, Jessica Flechtner, Chief Scientific Officer, Genocea, Jennifer Busby, Senior Director of Mass Spectrometry and Proteomics, Gritstone Oncology, Norbert Hilf, Director of Translational Development, Immatics, John Wang, Chief Executive Officer, IOVaxis, Trevor Clancy, Chief Scientific Officer, OncoImmunity, Sean Boyle, Director, Bioinformatics Applications, Personalis, Agnete Fredriksen, Chief Scientific Officer, Vaccibody, Laurence Cooper, Chief Executive Officer, Ziopharm, Hans Keirstead, Chief Executive Officer, AIVITA Biomedical, Michael Stein, Executive Chairman, Valo Therapeutics, Anna Pasetto, Assistant Professor, Karolinska Institutet

Time: 8:00 am - 5:00 pm

Location

Map and directions
Conference address :
Amsterdam Marriott Hotel
12 Stadhouderskade
1054 ES Amsterdam
Netherlands
Map and directions

Further information

To access the information you need to be connected. Creating an account is easy and free!

Log to your account
Register on Doctorama

Details

European NeoAg Summit 2019 Pharmacy
pharmaceuticals
Everyone
-- -- --
English

Other

For more information on European NeoAg Summit 2019, plsase contactr Hanson Wade

To obtain a letter of invitation, you must be logged

Log to my account
Register on Doctorama


Recommend this event